Clinical research in diabetic complications, main focus on diabetic nephropathy and cardiovascular disease

clinical trials, biomarker discovery with targeted and untargeted methods

metabolomics in relation to progresion of type 1 and type 2 diabetes, liver disease and diabetic complications

Diabetic nephropathy, cardiovascular disease, neuropathy, metabolomics

Focus on late diabetic complications,

biomarkers predicting risk for initiation or progression of complications,

clinical studies of interventions aiming at preventing or treating complications

improving understanding of pathophysiology of complications